City
Epaper

Japan preparing to launch COVID-19 vaccination by late February, says PM Suga

By ANI | Updated: January 4, 2021 13:10 IST

Japan is planning to launch COVID-19 vaccination by late February, Prime Minister Yoshihide Suga said on Monday.

Open in App

Japan is planning to launch COVID-19 vaccination by late February, Prime Minister Yoshihide Suga said on Monday.

The country has agreements with Pfizer/BioNTech for 120 million vaccine doses, UK-Swedish pharmaceutical giant AstraZeneca for another 120 million doses and US company Moderna for 50 million doses.

"The government is preparing to start vaccination, if possible, by the end of February, while continuing to study safety and effectiveness of [vaccines]," Suga told a press conference.

The Japanese Health Ministry earlier reported that once a coronavirus vaccine gets authorization in the country, which is likely to occur in February, 10,000 medical workers will immediately receive shots. On March, 4 million health care workers are expected to get inoculated.

Starting from April, people with chronic cardiovascular diseases, diseases of kidneys, lungs, liver, oncology patients, as well as people with obesity (body mass index above 30) will also be able to get shots.

In early December, the Japanese parliament passed a bill to make vaccination against the coronavirus free to residents. (/Sputnik)

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: AstrazenecaYoshihide SugaModernaModerna inc.Astrazeneca plc.
Open in App

Related Stories

HealthDCGI Orders Withdrawal of AstraZeneca’s Anti-Cancer Drug Olaparib for Certain Treatments

HealthAfter Covishield, BHU Study Reveals Side Effects of Covaxin; Including Hair Loss, Skin Issues, and Menstrual Irregularities

InternationalAstraZeneca Withdraws COVID-19 Vaccine Globally Days After Side Effect Row, Firm Says Decision ‘Commercial’

NationalCovaxin-Developer Bharat Biotech Amid Reports on AstraZeneca Vaccine, Says ‘Safety Is Primary Focus for All Our Vaccines’

NationalCovishield Vaccine Side Effect: Serum Institute Faces Legal Action As Parents of Deceased Girls Prepare Lawsuit

International Realted Stories

InternationalJaishankar focuses on easing trade barriers and boosting connectivity at IRIGC-TEC in Moscow

InternationalChinese envoy highlights 10 points of consensus in talks between India, China SRs on boundary question

InternationalIndia rejects Nepal's objection to Lipulekh trade agreement with China, calls territorial claims "untenable"

InternationalNepal objects agreement of India-China to open trade route via Lipulekh, asserting its claim

InternationalIndia-Russia trade turnover surges 700% in 5 years: Deputy PM after meeting with EAM Jaishankar